INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL
|
0.720 |
Biomarker
|
disease |
BEFREE |
The results show that in the absence of integrin α3 ILNEB keratinocytes produce a fibronectin-rich microenvironment and make use of fibronectin-binding integrin subunits αv and α5.
|
30466509 |
2018 |
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL
|
0.720 |
CausalMutation
|
disease |
CLINVAR |
Molecular diagnostic experience of whole-exome sequencing in adult patients.
|
26633545 |
2016 |
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
Integrin α3 (ITGA3) gene mutations are associated with Interstitial Lung disease, Nephrotic syndrome and Epidermolysis bullosa (ILNEB syndrome).
|
27717396 |
2016 |
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Integrin α3 (ITGA3) gene mutations are associated with Interstitial Lung disease, Nephrotic syndrome and Epidermolysis bullosa (ILNEB syndrome).
|
27717396 |
2016 |
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL
|
0.720 |
GeneticVariation
|
disease |
CLINVAR |
Molecular diagnostic experience of whole-exome sequencing in adult patients.
|
26633545 |
2016 |
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Integrin α3 mutations with kidney, lung, and skin disease.
|
22512483 |
2012 |
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
[Application of polarization fluorescence to the study on the effects of oxidative stress on wheat chloroplast].
|
22512183 |
2012 |
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Integrin α3 mutations with kidney, lung, and skin disease.
|
22512483 |
2012 |
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL
|
0.720 |
Biomarker
|
disease |
CTD_human |
|
|
|
Junctional Epidermolysis Bullosa
|
0.330 |
Biomarker
|
disease |
BEFREE |
Junctional epidermolysis bullosa (JEB) is a hereditary blistering disease caused by reduced dermal-epidermal adhesion due to deficiencies of one of the proteins, laminin-332, type XVII collagen, integrin α6β4 or integrin α3.
|
30761300 |
2018 |
Junctional Epidermolysis Bullosa
|
0.330 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recently Identified Forms of Epidermolysis Bullosa.
|
26719633 |
2015 |
Junctional Epidermolysis Bullosa
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Interstitial lung disease, nephrotic syndrome and junctional epidermolysis bullosa is an autosomal recessive multiorgan disorder caused by mutations in the gene for the integrin α3 subunit (ITGA3).
|
25810266 |
2015 |
Junctional Epidermolysis Bullosa
|
0.330 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome.
|
23114595 |
2012 |
Junctional Epidermolysis Bullosa
|
0.330 |
Biomarker
|
disease |
BEFREE |
Integrin alpha 3 beta 1 which is specifically involved in migration and adhesion of keratinocytes on nicein does not appear altered in JEB.
|
7967512 |
1994 |
EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recently Identified Forms of Epidermolysis Bullosa.
|
26719633 |
2015 |
EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome.
|
23114595 |
2012 |
Diabetes Mellitus, Experimental
|
0.200 |
Biomarker
|
disease |
RGD |
Spironolactone ameliorates podocytic adhesive capacity via restoring integrin alpha 3 expression in streptozotocin-induced diabetic rats.
|
20525748 |
2010 |
Glomerulonephritis
|
0.200 |
Biomarker
|
disease |
RGD |
Podocyte foot process effacement in very early phase of passive Heymann nephritis is not a prerequisite for proteinuria.
|
19662603 |
2009 |
Myocardial Infarction
|
0.200 |
Biomarker
|
disease |
RGD |
Cardiac myofibroblast differentiation is attenuated by alpha(3) integrin blockade: potential role in post-MI remodeling.
|
19041328 |
2009 |
Hyperalgesia
|
0.200 |
Biomarker
|
phenotype |
RGD |
Primary afferent second messenger cascades interact with specific integrin subunits in producing inflammatory hyperalgesia.
|
15836982 |
2005 |
Hyperalgesia
|
0.200 |
Biomarker
|
phenotype |
RGD |
Integrin signaling in inflammatory and neuropathic pain in the rat.
|
14984413 |
2004 |
Cardiomegaly
|
0.200 |
Biomarker
|
phenotype |
RGD |
Expression of collagen binding integrins during cardiac development and hypertrophy.
|
1835909 |
1991 |
Lung Diseases, Interstitial
|
0.140 |
Biomarker
|
group |
BEFREE |
Integrin α3 deficiency leads to interstitial lung disease, nephrotic syndrome and epidermolysis bullosa (ILNEB), an autosomal recessive multiorgan disease characterized by basement membrane abnormalities in skin, lung and kidney.
|
30466509 |
2018 |
Nephrotic Syndrome
|
0.140 |
GeneticVariation
|
group |
BEFREE |
Integrin α3 (ITGA3) gene mutations are associated with Interstitial Lung disease, Nephrotic syndrome and Epidermolysis bullosa (ILNEB syndrome).
|
27717396 |
2016 |